Eplivanserin/volinanserin is a combination of eplivanserin and volinanserin, both of which are selective serotonin 5-HT2A receptor antagonists, which is under development for the treatment of psychiatric and neurological disorders.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.